Content
All Posts > Content under Press Releases/IR
BiondVax Universal Flu Vaccine Patent Granted In India
Article By:
PR Newswire
Read
Tuesday, January 2, 2018 10:05 AM EDT
With a population of over 1.3 billion people, and high population density in some of the major cities, India is an important potential market for BiondVax and a universal flu vaccine may significantly improve public health.
In this article: BVXV
BiondVax Plans Phase 3 Clinical Trial Following Receipt Of Scientific Advice From The European Medicines Agency (EMA)
Article By:
PR Newswire
Read
Wednesday, December 27, 2017 12:00 PM EDT
BiondVax Pharmaceuticals Ltd. announced today that the European Medicines Agency (EMA)'s Committee for Medicinal Products for Human Use (CHMP) reviewed BiondVax's Phase 3 trial plan, provided advice, and allowed the Company to proceed.
In this article: BVXV
Guaranty Federal Bancshares, Inc Announces Quarterly Dividend
Article By:
NASDAQ GlobeNewswire
Read
Friday, December 22, 2017 3:35 PM EDT
Guaranty Federal Bancshares, Inc., today announces a dividend per common share of $.12 for its fourth quarter ending December 31, 2017.
In this article: GFED
Payment Data Systems Announces $3 Million Registered Direct Offering Of Its Common Stock
Article By:
NASDAQ GlobeNewswire
Read
Thursday, December 21, 2017 11:26 PM EDT
Payment Data Systems, Inc., today announced it has agreed to the sale and issuance to institutional investors of 1,176,000 shares of common stock in a registered direct offering with gross proceeds of approximately $3 million.
In this article: PYDS
Yield10 Bioscience Announces Closing Of $14.5 Million Public Offering
Article By:
NASDAQ GlobeNewswire
Read
Thursday, December 21, 2017 3:22 PM EDT
Yield10 Bioscience, Inc. today announced the closing of an underwritten public offering of units for gross proceeds of $14.5 million.
In this article: YTEN
Catalyst Biosciences Announces Pricing Of Public Offering Of Common Stock
Article By:
NASDAQ GlobeNewswire
Read
Wednesday, December 20, 2017 9:01 PM EDT
Catalyst Biosciences, Inc., today announced the pricing of an underwritten public offering of 1,105,263 shares of its common stock, offered at a price of $9.50 per share to the public.
In this article: CBIO
ImmuCell Corporation Announces Pricing Of $3 Million Public Offering Of Common Shares
Article By:
NASDAQ GlobeNewswire
Read
Tuesday, December 19, 2017 8:15 PM EDT
ImmuCell Corporation, today announced an underwritten public offering of 417,807 shares of common stock at a price to the public of $7.30 per share.
In this article: ICCC
Madrigal Pharmaceuticals Announces Proposed Public Offering Of Common Stock
Article By:
NASDAQ GlobeNewswire
Read
Monday, December 18, 2017 1:08 PM EDT
Madrigal Pharmaceuticals, Inc., today announced that it has commenced an underwritten public offering of $100 million of its common stock.
In this article: MDGL
Global Blood Therapeutics Prices A $100.0 Million Common Stock Public Offering
Article By:
NASDAQ GlobeNewswire
Read
Friday, December 15, 2017 9:49 AM EDT
Global Blood Therapeutics, Inc. today announced the pricing of its underwritten public offering of its common stock for gross proceeds of approximately $100.0 million.
In this article: GBT
Acer Therapeutics Announces Pricing Of Underwritten Public Offering Of Common Stock
Article By:
NASDAQ GlobeNewswire
Read
Wednesday, December 13, 2017 12:30 AM EDT
The underwritten public offering of 916,667 shares of its common stock is set at a public offering price of $12.00 per share.
In this article: ACER
Churchill Downs Incorporated Announces Proposed Offering Of $300 Million Of Senior Notes Due 2028
Article By:
NASDAQ GlobeNewswire
Read
Tuesday, December 12, 2017 9:42 AM EDT
Churchill Downs Incorporated, today announced that it intends to offer, subject to market and customary conditions, $300 million in aggregate principal amount of senior notes due 2028 (the “Notes”) in a private offering.
In this article: CHDN
Globalstar Announces Secondary Offering Of Voting Common Stock
Article By:
NASDAQ GlobeNewswire
Read
Friday, December 8, 2017 3:39 AM EDT
Globalstar, Inc. today announced an offering of 38,000,000 shares of Globalstar’s voting common stock on an underwritten basis by FL Investment Holdings, LLC.
In this article: GSAT
Editas Medicine, Inc., Announces Pricing Of $50 Million Offering Of Common Stock
Article By:
NASDAQ GlobeNewswire
Read
Wednesday, December 6, 2017 12:25 PM EDT
Editas Medicine, Inc., a leading genome editing company, today announced the pricing of an underwritten offering of 1,970,000 shares of its common stock.
In this article: EDIT
Providence Service Corporation Declares Cash Dividend On Convertible Preferred Stock
Article By:
NASDAQ GlobeNewswire
Read
Friday, December 1, 2017 11:01 AM EDT
The Providence Service Corporation, today announced that its Board of Directors has declared a cash dividend on its 5.5%/8.5% Series A convertible preferred stock.
In this article: PRSC
Cesca Therapeutics Inc. Announces Pricing Of Public Offering Of Up To 900,000 Shares Of Common Stock
Article By:
NASDAQ GlobeNewswire
Read
Wednesday, November 29, 2017 1:35 PM EDT
Cesca Therapeutics Inc., today announced that it has priced a best efforts registered public offering of up to an aggregate of 900,000 shares of the Company’s common stock at a price to the public of $3.00 per share.
In this article: KOOL
BiondVax Provides Third Quarter 2017 Financial Results And Update
Article By:
PR Newswire
Read
Tuesday, November 28, 2017 11:16 AM EDT
BiondVax Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on developing and commercializing M-001, a universal flu vaccine candidate, today announced its financial results for the quarter ended September 30, 2017.
In this article: BVXV